Sing Andreas, Rost Dagmar, Tvardovskaia Natalia, Roggenkamp Andreas, Wiedemann Agnès, Kirschning Carsten J, Aepfelbacher Martin, Heesemann Jürgen
Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, Ludwig-Maximilians-Universität München, Pettenkoferstrasse 9a, Germany.
J Exp Med. 2002 Oct 21;196(8):1017-24. doi: 10.1084/jem.20020908.
A characteristic of the three human-pathogenic Yersinia spp. (the plague agent Yersinia pestis and the enteropathogenic Yersinia pseudotuberculosis and Yersinia enterocolitica) is the expression of the virulence (V)-antigen (LcrV). LcrV is a released protein which is involved in contact-induced secretion of yersinia antihost proteins and in evasion of the host's innate immune response. Here we report that recombinant LcrV signals in a CD14- and toll-like receptor 2 (TLR2)-dependent fashion leading to immunosuppression by interleukin 10 induction. The impact of this immunosuppressive effect for yersinia pathogenesis is underlined by the observation that TLR2-deficient mice are less susceptible to oral Y. enterocolitica infection than isogenic wild-type animals. In summary, these data demonstrate a new ligand specificity of TLR2, as LcrV is the first known secreted and nonlipidated virulence-associated protein of a Gram-negative bacterium using TLR2 for cell activation. We conclude that yersiniae might exploit host innate pattern recognition molecules and defense mechanisms to evade the host immune response.
三种人类致病性耶尔森氏菌属细菌(鼠疫病原体鼠疫耶尔森氏菌以及肠道致病性假结核耶尔森氏菌和小肠结肠炎耶尔森氏菌)的一个特征是毒力(V)抗原(LcrV)的表达。LcrV是一种分泌蛋白,参与接触诱导的耶尔森氏菌抗宿主蛋白的分泌以及逃避宿主的天然免疫反应。在此我们报告,重组LcrV以依赖CD14和Toll样受体2(TLR2)的方式发出信号,通过诱导白细胞介素10导致免疫抑制。TLR2缺陷小鼠比同基因野生型动物对口服小肠结肠炎耶尔森氏菌感染的易感性更低,这一观察结果突出了这种免疫抑制作用对耶尔森氏菌发病机制的影响。总之,这些数据证明了TLR2的一种新的配体特异性,因为LcrV是已知的第一种利用TLR2进行细胞激活的革兰氏阴性细菌的分泌型且非脂化的毒力相关蛋白。我们得出结论,耶尔森氏菌可能利用宿主天然模式识别分子和防御机制来逃避宿主免疫反应。